Growth in the Concurrent Use of Antipsychotics With Other Psychotropic Medications in Medicaid-Enrolled Children
- 1 September 2014
- journal article
- Published by Elsevier in Journal of the American Academy of Child & Adolescent Psychiatry
- Vol. 53 (9) , 960-970.e2
Abstract
No abstract availableKeywords
This publication has 43 references indexed in Scilit:
- Prescribing trends of antipsychotics in youth receiving income assistance: results from a retrospective population database studyBMC Psychiatry, 2013
- Antipsychotic Treatment Among Youth in Foster CarePediatrics, 2011
- Antipsychotic Medication Use Among Children and Risk of Diabetes MellitusPediatrics, 2011
- Metabolic and endocrine adverse effects of second-generation antipsychotics in children and adolescents: A systematic review of randomized, placebo controlled trials and guidelines for clinical practiceEuropean Psychiatry, 2011
- National Trends in Child and Adolescent Psychotropic Polypharmacy in Office-Based Practice, 1996-2007Journal of the American Academy of Child & Adolescent Psychiatry, 2010
- Cardiometabolic Risk of Second-Generation Antipsychotic Medications During First-Time Use in Children and AdolescentsJAMA, 2009
- Broadened Use Of Atypical Antipsychotics: Safety, Effectiveness, And Policy ChallengesHealth Affairs, 2009
- Adjunctive olanzapine treatment in bipolar adolescents responding insufficiently to mood stabilizersEuropean Child & Adolescent Psychiatry, 2006
- Effect of Medicaid Eligibility Category on Racial Disparities in the Use of Psychotropic Medications Among YouthsPsychiatric Services, 2005
- Concomitant Pharmacotherapy among Youths Treated in Routine Psychiatric PracticeJournal of Child and Adolescent Psychopharmacology, 2005